c-myc null cells misregulate cad and gadd45 but not other proposed c- Myc targets

Genes and Development

Volumn 12, Issue 24, 1998, Pages 3797-3802

  Bush, Andrew ^a   Mateyak, Maria ^b   Dugan, Kerri ^a   Obaya, Alvaro ^b   Adachi, Susumu ^b   Sedivy, John ^b   Cole, Michael ^a  

^a PRINCETON UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

c myc; Cell cycle; Proliferation; Target genes; Transcription

Indexed keywords

CELL CYCLE PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROTEIN P53; RIBOSOME RNA;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; MOUSE; NONHUMAN; NULL CELL; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032535177     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.24.3797     Document Type: Article

References (27)

1. Armelin, H., M. Armelin, K. Kelly, T. Stewart, P. Leder, B. Cochran, and C. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310: 655-660.
2. Bello-Fernandez, C., G. Packham, and J.L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. 90: 7804-7808.
3. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes & Dev. 6: 2513-2523.
4. Boyd, K.E. and P.J. Farnham. 1997. Myc versus USF: Discrimination at the cad gene is determined by core promoter elements. Mol Cell. Biol. 17: 2529-2537.
5. Brough, D.E., T.J. Hofmann, K.B. Ellwood, R.A. Townley, and M.D. Cole. 1995. An essential domain of the c-Myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol. Cell. Biol. 15: 1536-1544.
6. Colman, M.S. and M.C. Ostrowski. 1996. The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling. Nucleic Acids Res. 24: 1971-1978.
7. Eilers, M., D. Picard, K.R. Yamamoto, and J.M. Bishop. 1989. Chimeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340: 66-68.
8. Eilers, M., S. Schirm, and J.M. Bishop. 1991. The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10: 133-142.
9. Facchini, L.M., S. Chen, W.W. Marhin, J.N. Lear, and L.Z. Penn. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-Myc P2 minimal promoter. Mol Cell. Biol. 17: 100-114.
10. Galaktionov, K., A.K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach. 1995. CDC25 phosphatases as potential human oncogenes. Science 269: 1575-1577.
11. Galaktionov, K., X. Chen, and D. Beach. 1996. CDC25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
12. Grandori, C., J. Mac, F. Siebelt, D.E. Ayer, and R.N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15: 4344-4357.
13. Hann, S.R., C.B. Thompson, and R.N. Eisenman. 1985. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314: 366-369.
14. Henriksson, M. and B. Lüscher. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109-182.
15. Hurlin, P., C. Queva, and R. Eisenman. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and me-diates repression at Myc binding sites. Genes & Dev. 11: 44-58.
16. Jones, R.M., J. Brands, K.A. Johnston, M. Polymenis, M. Gadd, A. Rustige, L. Callanan, and E.V. Schmidt. 1996. An essential E box in the promoter of the gene encoding the mRNA cap binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16: 4754-4764.
17. Padgett, R.A., G.M. Wahl, P.P. Coleman, and G.R. Stark. 1979. N-(Phosphonacetyl]-L-aspartate-resistant hamster cells overaccumulate a single mRNA coding for the multifunctional protein that catalyzes the first steps of UMP synthesis. J. Biol. Chem. 254: 974-980.
18. Penn, L.J.Z., M.W. Brooks, E.M. Laufer, T.D. Littlewood, J.P. Morgenstern, G.I. Evan, W.M.F. Lee, and H. Land. 1990. Domains of human c-Myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol. Cell. Biol. 10: 4961-4966.
19. Reisman, D., N.B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4: 57-65.
20. Shim, H., C. Dolde, B. Lewis, C.S. Wu, G. Dang, R.A. Jungmann, R. Dalla-Favera, and C.V. Dang. 1997. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. 94: 6658-6663.
21. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22: 427-433.
22. Tsuneoka, M., F. Nakano, H. Ohgusu, and E. Mekada. 1997. c-myc activates RCC1 gene expression through E-box elements. Oncogene 14: 2301-2311.
23. Waf1/cip1. Oncogene 12: 2579-2594.
24. Wagner, A.J., C. Meyers, L. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4: 879-883.
25. Xiao, Q. G.Claassen, J. Shi, S. Adachi, J. Sedivy, and S.R. Hann. 1998. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes & Dev. 12: (this issue).
26. Yokoyama, K., and F. Imamoto. 1987. Transcriptional control of the endogenous MYC protooncogene by antisense RNA. Proc. Natl. Acad. Sci. 84: 7363-7367.
27. Zhan, Q., K.A. Lord, I. Alamo, M.C. Hollander, F. Carrier, D. Ron, K. Kohn, B. Hoffman, L.D.A., and A.J. Fornace. 1994. The gadd and Myd genes define a novel set of mammalian genes encoding acidic proteins that synergestically suppress cell growth. Mol. Cell Biol. 14: 2361-2371.